Loss of TBX3 enhances pancreatic progenitor generation from human pluripotent stem cells.


Journal

Stem cell reports
ISSN: 2213-6711
Titre abrégé: Stem Cell Reports
Pays: United States
ID NLM: 101611300

Informations de publication

Date de publication:
09 11 2021
Historique:
received: 12 10 2020
revised: 13 09 2021
accepted: 14 09 2021
pubmed: 16 10 2021
medline: 15 3 2022
entrez: 15 10 2021
Statut: ppublish

Résumé

Tbx3 has been identified as a regulator of liver development in the mouse, but its function in human liver development remains unknown. TBX3 mutant human pluripotent stem cell (PSC) lines were generated using CRISPR/Cas9 genome editing. TBX3 loss led to impaired liver differentiation and an upregulation of pancreatic gene expression, including PDX1, during a hepatocyte differentiation protocol. Other pancreatic genes, including NEUROG3 and NKX2.2, displayed more open chromatin in the TBX3 mutant hepatoblasts. Using a pancreatic differentiation protocol, cells lacking TBX3 generated more pancreatic progenitors and had an enhanced pancreatic gene expression signature at the expense of hepatic gene expression. These data highlight a potential role of TBX3 in regulating hepatic and pancreatic domains during foregut patterning, with implications for enhancing the generation of pancreatic progenitors from PSCs.

Identifiants

pubmed: 34653400
pii: S2213-6711(21)00480-X
doi: 10.1016/j.stemcr.2021.09.004
pmc: PMC8580886
pii:
doi:

Substances chimiques

T-Box Domain Proteins 0
TBX3 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2617-2627

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK118155
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK123162
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Science. 1999 Jun 18;284(5422):1998-2003
pubmed: 10373120
Stem Cell Reports. 2017 Nov 14;9(5):1387-1394
pubmed: 29056335
Nat Biotechnol. 2014 Nov;32(11):1121-33
pubmed: 25211370
Stem Cells. 2013 Nov;31(11):2432-42
pubmed: 23897760
Stem Cell Reports. 2017 Mar 14;8(3):589-604
pubmed: 28196690
Genes Dev. 2001 Aug 1;15(15):1998-2009
pubmed: 11485993
Cancer Res. 2008 Oct 1;68(19):7872-81
pubmed: 18829543
Nat Biotechnol. 2006 Nov;24(11):1392-401
pubmed: 17053790
Diabetologia. 2012 Mar;55(3):694-706
pubmed: 22120512
Development. 2014 Feb;141(3):685-96
pubmed: 24449844
Hepatology. 2010 Jan;51(1):297-305
pubmed: 19998274
Development. 1996 May;122(5):1409-16
pubmed: 8625829
Hum Mol Genet. 2001 Oct 1;10(21):2403-13
pubmed: 11689487
Dev Dyn. 2011 Mar;240(3):589-604
pubmed: 21287656
Curr Protoc Stem Cell Biol. 2019 Feb;48(1):e64
pubmed: 30358158
J Clin Invest. 2010 Oct;120(10):3713-21
pubmed: 20811152
Development. 1998 Jul;125(13):2499-509
pubmed: 9609833
Hepatology. 2009 Mar;49(3):969-78
pubmed: 19140222
Stem Cells. 2012 Oct;30(10):2152-63
pubmed: 22865636
Nat Genet. 1997 Jul;16(3):311-5
pubmed: 9207801
Nature. 2018 Dec;564(7734):114-118
pubmed: 30487608
Development. 2011 Mar;138(5):861-71
pubmed: 21270052
Development. 2001 Mar;128(6):871-81
pubmed: 11222142
Nature. 1997 Jan 16;385(6613):257-60
pubmed: 9000074
Nat Genet. 1999 Sep;23(1):67-70
pubmed: 10471501
Stem Cell Reports. 2015 Apr 14;4(4):578-90
pubmed: 25843046
Cell Mol Life Sci. 2012 Apr;69(8):1377-89
pubmed: 22130515
Genes Dev. 1998 Jun 1;12(11):1705-13
pubmed: 9620856
Development. 2013 Aug;140(15):3285-96
pubmed: 23861064
Stem Cell Res. 2020 Dec;49:102084
pubmed: 33202304
Gene Expr Patterns. 2011 Dec;11(8):476-83
pubmed: 21867776
Nat Biotechnol. 2020 Apr;38(4):460-470
pubmed: 32094658
J Pathol. 2019 Jun;248(2):191-203
pubmed: 30697731
Annu Rev Cell Dev Biol. 2009;25:221-51
pubmed: 19575677
Stem Cell Reports. 2013 Aug 29;1(3):248-65
pubmed: 24319661

Auteurs

Somdutta Mukherjee (S)

Graduate Program in Cell and Molecular Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Deborah L French (DL)

Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Paul Gadue (P)

Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: gaduep@chop.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH